| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.2 | 0.05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.007 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.13 | 9e-05 |